SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950137-07-003750
Filing Date
2007-03-14
Accepted
2007-03-14 11:07:20
Documents
7
Period of Report
2007-03-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c13265e8vk.htm 8-K 14980
2 UNDERWRITING AGREEMENT c13265exv1w1.htm EX-1.1 99309
3 FORM OF 5.20% NOTE DUE 2017 c13265exv4w2.htm EX-4.2 30683
4 FORM OF 5.50% NOTE DUE 2027 c13265exv4w3.htm EX-4.3 30722
5 FORM OF 5.55% NOTE DUE 2037 c13265exv4w4.htm EX-4.4 30719
6 OPINION AND CONSENT OF DEWEY BALLANTINE LLP c13265exv5w1.htm EX-5.1 7291
7 OPINION AND CONSENT OF JAMES B. LOOTENS, ESQ. c13265exv5w2.htm EX-5.2 7229
  Complete submission text file 0000950137-07-003750.txt   222456
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 07692538
SIC: 2834 Pharmaceutical Preparations